Elevated plasma chitotriosidase activity in various lysosomal storage disorders

被引:173
|
作者
Guo, YF
He, W
Boer, AM
Wevers, RA
deBruijn, AM
Groener, JEMM
Hollak, CEM
Aerts, JMFG
Galjaard, H
vanDiggelen, OP
机构
[1] ERASMUS UNIV ROTTERDAM,DEPT CLIN GENET,3000 DR ROTTERDAM,NETHERLANDS
[2] UNIV NIJMEGEN HOSP,INST NEUROL,6500 HB NIJMEGEN,NETHERLANDS
[3] ERASMUS UNIV ROTTERDAM,DEPT EPIDEMIOL & BIOSTAT,3000 DR ROTTERDAM,NETHERLANDS
[4] LEIDEN UNIV,CLIN GENET CTR,LEIDEN,NETHERLANDS
[5] UNIV AMSTERDAM,ACAD MED CTR,DEPT BIOCHEM,1105 AZ AMSTERDAM,NETHERLANDS
关键词
D O I
10.1007/BF02436762
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recently a striking elevation of the activity of chitotriosidase, an endo beta-glucosaminidase distinct from lysozyme, was found in plasma from patients with Gaucher type I disease (McKusick 230800). Plasma chitotriosidase originates from activated macrophages and this elevation is secondary to the basic defect in Gaucher disease. To investigate the specificity of this phenomenon, we have investigated 24 different lysosomal storage diseases. In 11 different diseases increased chitotriosidase activity in plasma was found (in 28% of the patients). None of these diseases showed elevations as high as in Gaucher disease. Chitotriosidase was not significantly elevated in plasma from 20 different non-lysosomal enzymopathies or in plasma from patients with infectious diseases associated with hepatomegaly. The results show that marked elevation of chitotriosidase activity in plasma appears to be specific for Gaucher disease. The data further suggest that elevated levels of chitotriosidase activity in plasma from patients with unexplained diseases may be indicative for a lysosomal disorder.
引用
收藏
页码:717 / 722
页数:6
相关论文
共 50 条
  • [31] Plasma chitotriosidase activity and malaria - Response
    Musumeci, S
    CLINICA CHIMICA ACTA, 2005, 353 (1-2) : 217 - 217
  • [32] Plasma chitotriosidase activity in multiple sclerosis
    Comabella, M.
    Dominguez, C.
    Rio, J.
    Martin-Gallan, P.
    Vilches, A.
    Vilarrasa, N.
    Espejo, C.
    Montalban, X.
    CLINICAL IMMUNOLOGY, 2009, 131 (02) : 216 - 222
  • [33] Chitotriosidase plasma activity in nephropathic cystinosis
    Xaidara, A.
    Karavitakis, E. M.
    Kosma, K.
    Emma, F.
    Dimitriou, E.
    Michelakakis, H.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2009, 32 (01) : S157 - S159
  • [34] Saposins A, B, C, and D in plasma of patients with lysosomal storage disorders
    Chang, MHY
    Bindloss, CA
    Grabowski, GA
    Qi, XY
    Winchester, B
    Hopwood, JJ
    Meikle, PJ
    CLINICAL CHEMISTRY, 2000, 46 (02) : 167 - 174
  • [35] Sphingolipid lysosomal storage disorders
    Platt, Frances M.
    NATURE, 2014, 510 (7503) : 68 - 75
  • [36] Autophagy in lysosomal storage disorders
    Lieberman, Andrew P.
    Puertollano, Rosa
    Raben, Nina
    Slaugenhaupt, Susan
    Walkley, Steven U.
    Ballabio, Andrea
    AUTOPHAGY, 2012, 8 (05) : 719 - 730
  • [37] Radiology of Lysosomal Storage Disorders
    Kanekar, S.
    Pennypacker, J.
    Chetlen, A.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2007, 188 (05)
  • [38] Therapy for Lysosomal Storage Disorders
    Beck, Michael
    IUBMB LIFE, 2010, 62 (01) : 33 - 40
  • [39] DIAGNOSIS OF LYSOSOMAL STORAGE DISORDERS
    KERR, C
    MEDICAL JOURNAL OF AUSTRALIA, 1984, 140 (04) : 188 - 189
  • [40] Lysosomal Storage Disorders and Iron
    Bras, Jose Miguel
    METAL RELATED NEURODEGENERATIVE DISEASE, 2013, 110 : 251 - 275